|
Forecast Period
|
2025-2029
|
|
Market Size (2023)
|
USD 7.63 billion
|
|
Market Size (2029)
|
USD 11.12 Billion
|
|
CAGR (2024-2029)
|
6.65%
|
|
Fastest Growing Segment
|
Gelatin-Based/Animal-Based
|
|
Largest Market
|
North America
|
Market Overview
Global
Softgel Capsules Market was valued at USD 7.63 billion in 2023 and is
anticipated to project impressive growth in the forecast period with a CAGR of
6.65% through 2029. Softgel capsules provide numerous benefits in the field of
pharmaceuticals. They offer advantages such as easy ingestion, effective
concealment of odors and tastes, increased absorption, improved
bioavailability, and impressive stability in various environmental conditions.
As manufacturing technology continues to advance and new materials are
introduced, conventional capsules have undergone a transformation, now offering
additional functionalities such as controlled drug release, tamper-evident
features, and expanded possibilities for potent API formulations. These
developments are spurred by a decrease in degradation within the stomach's
acidic environment, aesthetically pleasing appearances, and extended shelf
life, thereby expanding the array of options available for pharmaceutical
formulations.
Key Market Drivers
Enhanced Bioavailability and
Absorption
The
global softgel capsules market is undergoing a remarkable transformation,
thanks to a multitude of factors that contribute to its expansion. Among these
factors, one of the most pivotal drivers is the promise of enhanced
bioavailability and absorption. Softgel capsules, due to their unique
characteristics and versatility, have become the preferred choice for
delivering a wide range of pharmaceutical and nutraceutical products.
Bioavailability
refers to the proportion of an active ingredient that enters the bloodstream
when introduced into the body, typically through ingestion, compared to the
amount administered. High bioavailability means a more significant portion of
the substance is available for the body to use, which is crucial for the
effectiveness of pharmaceuticals and dietary supplements. Absorption, on the
other hand, is the process by which the active ingredient is taken up and
distributed within the body after entering the bloodstream. In many cases, poor
absorption can significantly reduce the therapeutic efficacy of a drug or
supplement.
Softgel
capsules are unique in their ability to encapsulate both hydrophilic
(water-soluble) and lipophilic (fat-soluble) compounds. This versatility allows
for the efficient delivery of a broader range of active ingredients.
Pharmaceutical formulations, including those with poorly water-soluble
compounds, can achieve better bioavailability with softgel capsules. Softgel
capsules often contain liquid or semi-liquid formulations. This liquid core can
enhance the solubility of poorly soluble compounds, ensuring better absorption
in the gastrointestinal tract. Softgel capsules provide protection for the
encapsulated ingredients, shielding them from environmental factors like oxygen
and moisture. This preservation ensures that the active compounds remain stable
until they are released in the body, which can be critical for maintaining
bioavailability.
Pharmaceuticals,
particularly those with complex and poorly water-soluble compounds, are
increasingly turning to softgel capsules to maximize the bioavailability of
their products. This trend is boosting the demand for softgel capsules in the
pharmaceutical sector. As consumers become more discerning about the efficacy
of dietary supplements, softgel capsules are gaining popularity among
nutraceutical companies. The promise of better absorption attracts both
manufacturers and consumers. Softgel capsules allow for the customization of
drug release profiles. This means that pharmaceutical companies can tailor the
release of active ingredients to optimize bioavailability, further propelling
the growth of the softgel capsules market.
Improved Patient Compliance
The
global softgel capsules market is experiencing a robust upswing, and one of the
key accelerators behind this surge is the promise of improved patient
compliance. Softgel capsules, known for their ease of use and comfort, are
emerging as a preferred drug delivery system that not only enhances the
pharmaceutical and nutraceutical sectors but also ensures patients adhere to
their treatment regimens.
Patient
compliance, or adherence, refers to the extent to which a patient follows the prescribed
medical treatment or medication regimen. It is a critical factor in achieving
successful health outcomes and therapeutic efficacy. Factors that can affect
patient compliance include the complexity of the treatment regimen, side
effects, and the form of medication delivery.
The
most distinctive feature of softgel capsules is their ease of swallowing. The
gelatin-based shell is smooth and soft, making them more palatable and easier
to ingest. This is particularly beneficial for patients who have difficulty
swallowing traditional tablets or hard-shell capsules, such as children, the
elderly, and those with certain medical conditions. "Pill fatigue"
refers to the reluctance of patients to take multiple pills daily due to their
size, taste, or form. Softgel capsules offer a comfortable and convenient
alternative, reducing this psychological barrier to compliance. Softgel
capsules effectively mask the unpleasant tastes and odors of certain
medications or supplements. This plays a pivotal role in ensuring that patients
adhere to their treatment regimens, as they are less likely to encounter taste
aversion or nausea.
Softgel
capsules are increasingly being used in pediatric and geriatric medicine due to
their ease of administration. This has opened up new market segments and
opportunities for pharmaceutical manufacturers. In the nutraceutical industry,
where compliance with daily supplement regimens is paramount, softgel capsules
are gaining traction. They appeal to consumers seeking to maintain better
health through consistent supplement intake. Softgel capsules enhance the
acceptability of pharmaceutical products, particularly those with a reputation
for poor taste or size. Patients are more likely to continue their treatment
when it involves user-friendly delivery systems like softgel capsules. When
patients comply with their prescribed regimens, they are more likely to
experience improved therapeutic outcomes. This benefits both patients and
healthcare providers and fosters trust in the efficacy of softgel-encapsulated
drugs and supplements.
Download Free Sample Report
Key Market Challenges
Cost-Intensive Manufacturing
The production
of softgel capsules is a complex, multi-step process that includes the
formation of the gelatin shell, filling, sealing, and rigorous quality control
measures. Initially, gelatin is processed and formed into a flexible, yet
durable shell. This shell must meet stringent standards to ensure it can
effectively contain the active ingredients without compromising integrity. The
next stage involves precisely filling these shells with the active substances,
which can range from vitamins and supplements to pharmaceuticals. The filled
capsules are then sealed to protect the contents from environmental factors
such as moisture and oxygen, which can degrade the product.
Quality control
is a critical aspect of the production process, encompassing checks for
consistency, purity, and the correct dosage. These steps are
resource-intensive, requiring specialized equipment, skilled labor, and
adherence to stringent regulatory standards. Consequently, production costs can
be high, posing a significant challenge for manufacturers. They must balance
the need to maintain competitive pricing with the imperative of ensuring
product quality and profitability. This dynamic necessitates continuous
innovation and efficiency improvements within the production process to stay
competitive in the market.
Supply Chain Disruptions
Global supply
chains are increasingly susceptible to disruptions caused by a range of
factors, including pandemics, natural disasters, and geopolitical tensions.
These disruptions can have a significant impact on the timely acquisition of
raw materials and components, which in turn affects production schedules across
various industries. Pandemics, such
as the COVID-19 outbreak, can lead to widespread factory shutdowns, labor
shortages, and transportation restrictions. These factors can severely disrupt
the supply chain by delaying shipments and reducing the availability of
critical materials needed for production. Natural disasters, including
earthquakes, floods, and hurricanes, can damage infrastructure, halt
manufacturing operations, and disrupt transportation networks, further
complicating the flow of goods.
Geopolitical
tensions, such as trade wars, sanctions, and political instability, can lead to
sudden changes in trade policies and tariffs, affecting the cost and
availability of imported materials. These tensions can also create uncertainty
and unpredictability in the market, making it challenging for companies to
secure stable supply chains. The cumulative
effect of these disruptions necessitates robust risk management strategies for
companies reliant on global supply chains. Diversifying suppliers, investing in
local sourcing, and enhancing inventory management practices can help mitigate
the impact of such disruptions. Additionally, leveraging technology for
real-time supply chain monitoring and fostering strong relationships with
suppliers can enhance resilience and ensure more reliable production schedules.
Key Market Trends
Preference of Odor and Taste Masking Property
The global softgel capsules market is experiencing substantial growth, and a significant driving force behind this expansion is the remarkable capability of softgel capsules to mask undesirable tastes and odors. In the pharmaceutical and nutraceutical industries, product palatability plays a crucial role in patient and consumer acceptance. Softgel capsules have emerged as a versatile solution that not only protects sensitive ingredients but also offers a pleasant experience for users.
Softgel capsules are particularly adept at encapsulating both hydrophilic (water-soluble) and lipophilic (fat-soluble) compounds. This feature allows manufacturers to mask the taste and odor of active ingredients by enclosing them within a sealed, often flavored, gelatin shell. The external shell ensures that the sensitive ingredients are not exposed to the palate or olfactory senses. Manufacturers can add pleasant flavors to the liquid or semi-liquid fillings within softgel capsules. This customization not only helps mask unappealing tastes but also makes the medication or supplement more enjoyable to consume. Flavor options can range from fruity and sweet to minty or herbal, catering to a variety of preferences. Softgel capsules provide an additional barrier between the enclosed ingredients and external environmental factors, including oxygen and moisture. This protection further safeguards the integrity of the product, preventing potential degradation that could affect taste and odor.
Softgel capsules enhance the overall patient experience, making it more likely for patients to adhere to their prescribed medication regimens. This is especially crucial in the pharmaceutical industry, as patient compliance directly impacts the effectiveness of treatment. In the nutraceutical sector, where consumer acceptance is vital, softgel capsules provide a means to deliver supplements without the unpleasant aftertaste often associated with vitamins and minerals. Softgel capsules are gaining popularity among diverse demographics, including children, the elderly, and individuals with sensitivities to taste and odor. This expanding user base is opening new market segments for pharmaceutical and nutraceutical companies. The ability to offer a pleasant sensory experience can strengthen brand loyalty and trust in product efficacy. Consumers are more likely to repurchase products that are both effective and enjoyable to use.
Expansion of Shelf Life
The global softgel capsules market is experiencing rapid growth, and one of the key factors contributing to this expansion is the promise of extended shelf life. In an era of heightened consumer awareness and a focus on product efficacy, softgel capsules have emerged as a leading solution to protect the integrity of pharmaceutical and nutraceutical products.
Longer shelf life instills confidence in consumers that the product they purchase will remain effective until the expiration date. This trust is a critical factor for both pharmaceutical and nutraceutical products. Products with longer shelf lives are less likely to expire before consumption, reducing waste for both consumers and manufacturers. Extended shelf life enables products to reach a broader geographic market, as they can be stored for longer periods without deterioration.
Softgel capsules create a protective barrier between the product contents and external elements, such as oxygen, moisture, and light. This barrier ensures that the ingredients inside the capsules remain stable and potent throughout their designated shelf life. The gelatin shell of softgel capsules helps maintain the stability of the encapsulated ingredients. This is particularly important for sensitive compounds, including vitamins, minerals, and certain medications, which can degrade when exposed to environmental factors. Softgel capsules are highly effective in minimizing oxidation of ingredients susceptible to oxidative damage. Oxidation can result in loss of potency and spoilage, which extended shelf life effectively combats.
Products housed in softgel capsules inspire trust among consumers, who are more likely to purchase items with the assurance of longer shelf life. This is particularly vital for dietary supplements and over-the-counter medications. Products housed in softgel capsules inspire trust among consumers, who are more likely to purchase items with the assurance of longer shelf life. This is particularly vital for dietary supplements and over-the-counter medications. Products with longer shelf lives are less likely to expire before use, resulting in fewer returns for manufacturers and retailers. This reduction in waste benefits the entire supply chain. The ability to deliver products with extended shelf life enhances brand reputation and customer loyalty. Consumers are more likely to stick with brands that consistently provide fresh, potent products.
Segmental Insights
Type Insights
Based
on the category of Type, the gelatin-based or animal-based category emerged as
the dominant force in the market in 2023, boasting the largest share of
revenue. Gelatin has been the preferred choice for manufacturers for over 80
years, owing to its numerous advantages over alternative excipients. Its
exceptional attributes, including easy digestibility, efficient production of
tamper-proof capsules, superior durability, high-quality seals, patient
compliance, abundant availability as a resource, and its inert, clean-label
nature, have all played a pivotal role in its widespread acceptance within the
market. These factors have solidified gelatin's status as the excipient of
choice for pharmaceutical formulations.
In
contemporary times, manufacturers are exploring capsules that combine bovine
and porcine gelatin due to their distinctive properties. Bovine-derived gelatin
contributes to enhanced capsule firmness, while porcine-derived gelatin imparts
desirable qualities like plasticity and clarity to the formulation.
Despite
the numerous advantages of gelatin-based capsules, the non-animal-based capsule
sector is expected to experience significant growth at an attractive CAGR
during the forecast period. There is a growing preference for vegan medication
options, especially in the wake of the COVID-19 pandemic, which has led to
increased adoption of such capsules by vegetarian consumers. Furthermore, the
extensive research efforts undertaken by leading companies are likely to
further boost market growth.
Application Insights
Based
on Application, the vitamins and dietary supplements category emerged as the
dominant force in the market in 2023, securing the largest share of revenue.
Vitamins, when formulated as tablets or gummies, are susceptible to atmospheric
oxidation and degradation. Therefore, the optimal choice for formulation is
softgel capsules, as they provide protection against UV radiation and
oxidation, ultimately extending their shelf life.
Research
indicates that vitamins, when administered in the form of softgel capsules, are
absorbed more rapidly into the bloodstream compared to tablet formulations.
Thanks to these advantages, vitamins are predominantly marketed in softgel
capsule form, solidifying their significant presence in the application
segment. The outbreak of the COVID-19 pandemic resulted in countries like the
United States and India experiencing an approximately 89% increase in the sales
of Vitamin C and D supplements compared to 2019 figures.
In
the softgel capsules market, the health supplements sector also claimed a
noteworthy share of revenue in 2023. This growth was facilitated by the
increased adoption of a healthy lifestyle by the general population in response
to the COVID-19 pandemic. The widespread acceptance of pre- and post-natal
softgel capsules, combined with a preference for tasteless medication,
contributed significantly to the surge in softgel capsule sales, further
enhancing market expansion.
Download Free Sample Report
Regional Insights
In 2023, North America dominated the market,
capturing the largest revenue share. This success is attributed to advancements
in production technology, the strong presence of major industry players, and
increased investments in research and development to expand product offerings.
Additionally, the presence of health-conscious consumers and industry leaders
in the region significantly contributed to robust market growth.
In contrast, the Asia Pacific region is
expected to achieve the fastest CAGR during the forecast period. This
remarkable growth is driven by several factors, including the strong presence
of generic medicine manufacturers in China and India, increasing demand for
cost-effective therapeutics, rapid economic improvements, and the rise of
contract manufacturing organizations in the region. Additionally, increased
investment in personalized medicine and the adoption of advanced processing
techniques to improve softgel production are set to further accelerate the
regional market's progress.
Recent Developments
- In
January 2023, Sirio Pharma made an announcement regarding its acquisition of
Best Formulations, a company specializing in the production of plant-based
softgels, gummies, and related products. This acquisition is anticipated to
result in the expansion of Sirio Pharma's production capacity, diversification
of its product portfolio, and enhancement of its research and development
capabilities.
In April 2023, Darling Ingredients Inc.
(NYSE: DAR), the global leader in converting food waste into sustainable
products and renewable energy, finalized the acquisition of Gelnex, a prominent
worldwide manufacturer of gelatin and collagen products, on March 31, 2023.
Key Market Players
- Fuji
Capsule Co Ltd
- Sirio Pharma Co Ltd
- Captek Softgel International Inc
- Thermo Fisher Scientific Inc
- EyePoint Pharmaceuticals Inc
- Catalent Inc
- EuroCaps Ltd
- Aenova Group GmbH
- Lonza Group AG
- Soft Gel Technologies Inc
|
By Type
|
By Application
|
By End Use
|
By Region
|
- Gelatin-Based/Animal-Based
- Non-Animal-Based
|
- Antacid and Anti-Flatulent
Preparation
- Anti-Anemic Preparations
- Anti-Inflammatory Drugs
- Antibiotic and Antibacterial
Drugs
- Cough and Cold Preparations
- Health Supplement
- Vitamin and Dietary Supplement
- Pregnancy
- Others
|
- Pharmaceutical Companies
- Nutraceutical Companies
- Cosmeceutical Companies
- Contract Manufacturing
Organization
|
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
|
Report Scope:
In this report, the Global Softgel Capsules Market
has been segmented into the following categories, in addition to the industry
trends which have also been detailed below:
- Softgel Capsules Market, By Type:
o Gelatin-Based/Animal-Based
o Non-Animal-Based
- Softgel Capsules Market, By Application:
o Antacid and Anti-Flatulent Preparation
o Anti-Anemic Preparations
o Anti-Inflammatory Drugs
o Antibiotic and Antibacterial Drugs
o Cough and Cold Preparations
o Health Supplement
o Vitamin and Dietary Supplement
o Pregnancy
o Others
- Softgel Capsules Market, By End Use:
o Pharmaceutical Companies
o Nutraceutical Companies
o Cosmeceutical Companies
o Contract Manufacturing
Organization
- Softgel Capsules Market, By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ Germany
§ United Kingdom
§ France
§ Italy
§ Spain
o Asia-Pacific
§ China
§ Japan
§ India
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Softgel
Capsules Market.
Available Customizations:
Global Softgel Capsules market report with
the given market data, TechSci Research offers customizations according to a
company's specific needs. The following customization options are available for
the report:
Company Information
- Detailed analysis and profiling of additional
market players (up to five).
Global Softgel Capsules Market is an upcoming
report to be released soon. If you wish an early delivery of this report or
want to confirm the date of release, please contact us at [email protected]